Market cap
$28.554 B
$69.10 -1.04%
Close of 2 Oct 2026
As of 2 Oct 2026, Zoetis (ZTS) has a market capitalization of $28.6B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
$9.47B
#430 by revenue
Earnings
$2.67B
#175 by earnings
Shares outstanding
413,223,602
Latest filing cover page
P/E ratio
10.7
Cap ÷ net income
Biotechnology: Pharmaceutical Preparations, ranked by market cap
All 500 →- #18Royalty PharmaRPRX$33.1B
- #19Alnylam PharmaceuticalsALNY$30.9B
- #20ZoetisZTS$28.6B
- #21Roivant SciencesROIV$25.6B
- #22United TherapeuticsUTHR$24.5B
What if Zoetis were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Zoetis are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 3 Oct 2026. Read the methodology.